WATSON LABS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand and thirty-two approved drugs.
There are eighteen tentative approvals on WATSON LABS drugs.
Drugs and US Patents for WATSON LABS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | PHENYTEX | phenytoin sodium | CAPSULE;ORAL | 088711-001 | Dec 21, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Inc | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 062856-003 | Oct 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 075979-003 | Jan 24, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 071969-001 | Apr 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs | HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE | hydralazine hydrochloride; hydrochlorothiazide; reserpine | TABLET;ORAL | 083770-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for WATSON LABS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Here is a list of applicants with similar names.